Date Time
Researcher to test value of tailored gene testing
A Perth researcher is hoping to make a case for the upfront use of advanced DNA testing in patients with two of the most common forms of leukaemia.
Sir Charles Gairdner Hospital haematologist Dr Xuan Ni Tan is one of five cancer researchers awarded a State Government fellowship in the latest round of the WA Cancer and Palliative Care Network Fellowship program.
She will use her fellowship to determine whether the benefits of more targeted treatment can justify the costs of using advanced gene-sequencing technology to screen patients before they start treatment.
Boral (ASX:BLD) share price falls on sale of its US bricks business
Brendon Lau | December 18, 2020 4:42pm |
More on:
The
Boral Limited(ASX: BLD) share price lost ground on Friday after it announced the sale of its US joint venture bricks business.
The Boral share price tumbled 2% to $4.82 compared to the 1.2% decline in the the
Boral’s divestment yields small profit
Boral will receive half of the proceeds, which should translate to around a $10 million pre-tax profit for the group.
The divestment is subject to the usual conditions and regulatory approvals, but I don’t see any real impediments to the deal. The transaction should be finalised in FY21.